A detailed history of Guardian Investment Management transactions in Pfizer Inc stock. As of the latest transaction made, Guardian Investment Management holds 20,352 shares of PFE stock, worth $536,478. This represents 0.47% of its overall portfolio holdings.

Number of Shares
20,352
Previous 22,602 9.95%
Holding current value
$536,478
Previous $632,000 6.96%
% of portfolio
0.47%
Previous 0.43%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$27.7 - $31.39 $62,325 - $70,627
-2,250 Reduced 9.95%
20,352 $588,000
Q2 2024

Jul 23, 2024

SELL
$25.26 - $29.6 $128,775 - $150,900
-5,098 Reduced 18.4%
22,602 $632,000
Q1 2024

Apr 26, 2024

SELL
$25.89 - $29.73 $639,483 - $734,331
-24,700 Reduced 47.14%
27,700 $768,000
Q4 2023

Jan 31, 2024

SELL
$26.13 - $33.94 $183,040 - $237,749
-7,005 Reduced 11.79%
52,400 $1.51 Million
Q3 2023

Oct 13, 2023

SELL
$32.09 - $37.51 $48,135 - $56,265
-1,500 Reduced 2.46%
59,405 $1.97 Million
Q2 2023

Jul 14, 2023

SELL
$36.12 - $41.79 $744,288 - $861,124
-20,606 Reduced 25.28%
60,905 $2.23 Million
Q1 2023

May 05, 2023

BUY
$39.39 - $51.28 $727,966 - $947,705
18,481 Added 29.32%
81,511 $3.33 Million
Q3 2022

Oct 12, 2022

SELL
$43.76 - $53.42 $498,864 - $608,988
-11,400 Reduced 15.32%
63,030 $2.76 Million
Q2 2022

Jul 19, 2022

BUY
$46.53 - $55.17 $2,326 - $2,758
50 Added 0.07%
74,430 $3.95 Million
Q1 2022

Apr 22, 2022

SELL
$45.75 - $56.69 $93,787 - $116,214
-2,050 Reduced 2.68%
74,380 $3.85 Million
Q4 2021

Jan 19, 2022

BUY
$41.32 - $61.25 $16,528 - $24,500
400 Added 0.53%
76,430 $4.51 Million
Q3 2021

Oct 13, 2021

SELL
$39.25 - $50.42 $221,173 - $284,116
-5,635 Reduced 6.9%
76,030 $3.27 Million
Q2 2021

Jul 14, 2021

BUY
$35.91 - $40.68 $5,530 - $6,264
154 Added 0.19%
81,665 $3.2 Million
Q1 2021

Apr 14, 2021

BUY
$33.49 - $37.77 $217,685 - $245,505
6,500 Added 8.67%
81,511 $2.95 Million
Q4 2020

Jan 19, 2021

BUY
$33.47 - $42.56 $46,858 - $59,584
1,400 Added 1.9%
75,011 $2.76 Million
Q3 2020

Oct 13, 2020

BUY
$31.75 - $37.25 $15,875 - $18,625
500 Added 0.68%
73,611 $2.7 Million
Q2 2020

Jul 13, 2020

BUY
$30.12 - $36.54 $52,710 - $63,945
1,750 Added 2.45%
73,111 $2.39 Million
Q1 2020

May 07, 2020

BUY
$27.03 - $38.62 $231,106 - $330,201
8,550 Added 13.61%
71,361 $2.33 Million
Q4 2019

Jan 15, 2020

BUY
$32.92 - $37.36 $105,344 - $119,552
3,200 Added 5.37%
62,811 $2.46 Million
Q3 2019

Oct 24, 2019

BUY
$32.49 - $42.13 $8,317 - $10,785
256 Added 0.43%
59,611 $2.14 Million
Q2 2019

Aug 16, 2019

BUY
$36.98 - $41.52 $2,144 - $2,408
58 Added 0.1%
59,355 $2.57 Million
Q1 2019

Apr 22, 2019

SELL
$37.5 - $41.2 $191,250 - $210,120
-5,100 Reduced 7.92%
59,297 $2.52 Million
Q4 2018

Feb 06, 2019

SELL
$38.47 - $43.86 $26,929 - $30,702
-700 Reduced 1.08%
64,397 $2.81 Million
Q3 2018

Oct 19, 2018

BUY
$34.47 - $41.81 $60,839 - $73,794
1,765 Added 2.79%
65,097 $2.87 Million
Q2 2018

Jul 13, 2018

BUY
$32.98 - $35.16 $142,638 - $152,066
4,325 Added 7.33%
63,332 $2.3 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $53,382 - $56,640
1,605 Added 2.8%
59,007 $2.14 Million
Q3 2017

Oct 19, 2017

BUY
$31.0 - $34.15 $1.78 Million - $1.96 Million
57,402
57,402 $2.05 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Guardian Investment Management Portfolio

Follow Guardian Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Investment Management with notifications on news.